CLLS
CellectisDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CLLS vs peer average
45/100
CLLS vs. peer average (D vs. D)
Grade spread
B 2 · C 3 · D 1 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ARCT is the first available peer comparator.
A loose LNP-delivery and clinical-translation comparator from the prior baseline. Different therapeutic modality and pipeline maturity limit valuation read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLLS
Cellectis
ARCT
Arcturus Therapeutics
Grade
D
D
Momentum
95
57
Value
41
41
Sentiment
44
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ARCT
CLLS / ARCT
Grade Position
In line
CLLS vs. peer average (D vs. D)
45/100
Momentum
95
CLLSValue
41
CLLSSentiment
44
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLLS
ARCT is the first peer returned for this comparison set.